The estimated Net Worth of Todd Norbe is at least $593 ezer dollars as of 12 December 2018. Mr. Norbe owns over 15,000 units of Biolase Inc stock worth over $750 and over the last 6 years he sold BIOL stock worth over $0. In addition, he makes $592,590 as President, Chief Executive Officer és Director at Biolase Inc.
Todd has made over 1 trades of the Biolase Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 15,000 units of BIOL stock worth $15,450 on 12 December 2018.
The largest trade he's ever made was buying 15,000 units of Biolase Inc stock on 12 December 2018 worth over $15,450. On average, Todd trades about 1,250 units every 0 days since 2018. As of 12 December 2018 he still owns at least 15,000 units of Biolase Inc stock.
You can see the complete history of Mr. Norbe stock trades at the bottom of the page.
Todd A. Norbe serves as President, Chief Executive Officer, Director of the Company. Mr. Norbe was most recently President, North America of KaVo Kerr, a subsidiary of the Danaher Corporation, where he held executive leadership positions from 2006 to 2018. KaVo Kerr is comprised of two global leaders, KaVo and Kerr, that deliver dental instruments, imaging solutions, dental treatment units and premier consumables worldwide. Mr. Norbe was responsible for the integration of the KaVo and Kerr businesses. Prior to the integration, Mr. Norbe served as President of Kerr North America. Mr. Norbe also previously served as Vice President and General Manager of Metrex Medical – Sybron Dental Specialties, which was acquired by Danaher in 2006. Mr. Norbe earned a Master of Business Administration degree in Management from Fairleigh Dickinson University and a Bachelor of Science degree in Marketing from Bloomsburg University. He served on the Board of the Dental Trade Association Foundation and the National Children’s Oral Health Foundation. Mr. Norbe brings to our Board extensive management and operational experience, particularly in the dental industry.
As the President, Chief Executive Officer és Director of Biolase Inc, the total compensation of Todd Norbe at Biolase Inc is $592,590. There are no executives at Biolase Inc getting paid more.
Todd Norbe is 53, he's been the President, Chief Executive Officer és Director of Biolase Inc since 2018. There are 11 older and 3 younger executives at Biolase Inc. The oldest executive at Biolase Inc is Richard R. Whipp, 69, who is the VP of Operations.
Todd's mailing address filed with the SEC is 4, Cromwell, Serrano Place, Lake Forest, Orange County, California, 92618, United States of America.
Over the last 12 years, insiders at Biolase Inc have traded over $9,258,543 worth of Biolase Inc stock and bought 25,366,011 units worth $28,515,794 . The most active insiders traders include Jack W Schuler, Larry Noracle Partners Lp O... és Larry N Feinberg. On average, Biolase Inc executives and independent directors trade stock every 57 days with the average trade being worth of $31,910. The most recent stock trade was executed by Jonathan T Md Lord on 7 December 2022, trading 3,537 units of BIOL stock currently worth $2,653.
biolase, inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment. biolase’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. biolase is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.
Biolase Inc executives and other stock owners filed with the SEC include: